North America Anti Fungal Market Forecast 2017-2025
The North America antifungal agents market is anticipated to grow at a CAGR of 6.16% in the forecasted period of 2017-2025. The market was valued at $2220 million in 2016 and is expected to grow $3803 million by 2025. Initiatives taken by the government in healthcare policies and programs are some of the factors helping the market to surge ahead.
The antifungal agent market segmentation by drug types is on the basis of Echinocandins market, Azoles market, Polyenes market, Allylamines and others. It is further segmented by therapeutic indications on the basis of Aspergillosis, Dermatophytosis and Candidiasis market. It is further divided by applications on the basis of topical antifungal agents and Oral drugs market. poor hygiene and development in the exclusive drug resistance are the factors responsible for the growth of the antifungal market in the region. Alternation in the treatment options and conditions in regulation are the restraints faced by the anti-fungal market in Asia Pacific region.
The major market players in the anti-fungal market are Abbott Laboratories, Arbor PharmaceuticalsINC, Baxter, AstellasPharmaInc, Bayer Healthcare, Teva Pharmaceuticals, Gilead, GlaxoSmithKline, Johnson & Johnson, Kramer Laboratories, Merck Co, Novartis and Pfizer, Sanofi- Aventis, Vertex Pharmaceuticals.